← Open Payments lookup

KEVIN MAINZ: Open Payments

NPI 1205130853 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,043 in 68 payments from 19 companies in 2025. Trend: 2023 $3,440 · 2024 $3,111 · 2025 $2,043

Food & beverage: $1,944Education: $99
CompanyPaymentsAmount
Abbott Laboratories8$628
Novartis Pharmaceuticals Corporation16$288
Merck Sharp & Dohme LLC11$244
HEARTFLOW, INC.5$159
Actelion Pharmaceuticals US, Inc.1$99
Novo Nordisk Inc5$87
E.R. Squibb & Sons, L.L.C.2$87
ABIOMED2$66
Boston Scientific Corporation3$64
Boehringer Ingelheim Pharmaceuticals, Inc.3$58

Products named: LEQVIO, ASSURITY, VERQUVO, FFRct, AMPLATZER AMULET, MITRACLIP, MERLIN@HOME, OPSUMIT.

Industry payments across TX — which companies pay providers there.